BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20152210)

  • 1. Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    Solomon R
    Am Heart J; 2010 Feb; 159(2):e7; author reply e9. PubMed ID: 20152210
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    Laskey W; Aspelin P; Davidson C; Rudnick M; Aubry P; Kumar S; Gietzen F; Wiemer M;
    Am Heart J; 2009 Nov; 158(5):822-828.e3. PubMed ID: 19853704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
    Wessely R; Koppara T; Bradaric C; Vorpahl M; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):430-7. PubMed ID: 20031753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
    Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
    Anselmino M; Biondi-Zoccai G; Sheiban I
    Circulation; 2008 Feb; 117(7):e166; author reply e167. PubMed ID: 18285573
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of coronary injections of iodixanol, iopamidol, and ioxaglate on contractility and electrophysiology.
    Morris TW; Dukovic D; Pagani E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S99-101. PubMed ID: 7928282
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast-associated nephrotoxicity: ultrastructural and biochemical study in diabetic rats].
    Narasaki K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Aug; 57(9):586-95. PubMed ID: 9293757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodixanol and chronic kidney disease.
    Deray G
    J Invasive Cardiol; 2006 Feb; 18(2):84. PubMed ID: 16468162
    [No Abstract]   [Full Text] [Related]  

  • 11. Neural tolerance of the non-ionic dimers iodixanol and iotrolan and the non-ionic monomer iopamidol during myelography in non-anaesthetised rabbits.
    Maly P; Sundgren P; Bååth L; Walday P
    Acta Radiol; 1995 Nov; 36(6):644-8. PubMed ID: 8519577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
    Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
    Pettersson G; Towart R; Grant D; Thyberg K; Golman K
    Acad Radiol; 2002 May; 9 Suppl 1():S62-4. PubMed ID: 12019897
    [No Abstract]   [Full Text] [Related]  

  • 14. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sodium on the fibrillatory propensity of nonionic contrast media.
    Piao ZE; Murdock DK; Hwang MH; Raymond RM; Scanlon PJ
    Invest Radiol; 1987 Nov; 22(11):895-900. PubMed ID: 3429186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
    Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
    Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotonic contrast media is more toxic than isotonic contrast media on endothelial cells in vivo and in vitro.
    Ren L; Wang P; Wang Z; Liu Y; Lv S
    Mol Med Rep; 2017 Oct; 16(4):4334-4340. PubMed ID: 28731176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity of iopentol in rodents.
    Michelet AA; Salvesen S; Renaa T
    Acta Radiol Suppl; 1987; 370():41-4. PubMed ID: 2980310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
    Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
    J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.